Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.

Recent developments, awards & more

To receive our project newsletter please subscribe here!


  • Open position – PhD student (UNIBO)

    23 April 2021

    Apply until 21 May 2021: In the frame of the PhD program in Biotechnological, Biocomputational, Pharmaceutical and Pharmacological Sciences (B2F2), the Department of Pharmacy and Biotechnology (FaBiT) at UNIBO is looking for a PhD student as part of QSPainRelief! The selected applicant will join the Molecular and Cellular Pharmacology Unit to investigate gene expression and cellular signaling and to perform molecular pathway analysis in rat and mouse primary cultures from distinct brain regions as well as in human neuronal cell lines. This is aiming at developing and implementing an innovative Quantitative Systems Pharmacology platform for the identification of more effective and safer combinational treatments of chronic pain. If interested, please contact Dr. Andrea Bedini. For further information about the selection process, call for application, deadlines, and the admission board, click here.

    More information about the B2F2 department!

  • QSPainRelief Masterclass by Prof. Albert Dahan now online

    01 March 2021

    This is the first QSPainRelief Masterclass, held by our scientific and ethical advisory board (SEAB) member Prof. Dr. Albert Dahan from Leiden University Medical Center (LUMC) in Leiden, The Netherlands, during the project’s 2nd General Assembly (GA) Meeting on December 10th, 2020. As an expert on chronic pain treatment, he provides detailed insight on the current approaches used in the clinical treatment of chronic pain patients.

    Read More
  • First publication of the project by Jesús Giraldo

    17 November 2020

    The first QSPainRelief publication on the statistics of molecular dynamics simulations is out! Congrats to Prof. Jesús Giraldo and colleagues from Institut de Neurociències (INc) at the Universitat Autònoma de Barcelona (UAB) on this achievement!

    Read More
  • Prof. Liesbeth de Lange wins lifetime career award!

    13 November 2020

    Congrats to “the Ferrari of pharmacology”, our scientific coordinator, Prof. Liesbeth de Lange, who just won the “Lewis B. Sheiner Lifetime Achievement Award” from the International Society of Pharmacometrics (ISoP)! Read more.

  • The QSPainRelief info brochure is available!

    22 September 2020

    Click on the image below to access the web version of the project’s info folder and to download it!

  • Project video & successful 1st patient event at PAE’s annual GA Meeting!

    25 June 2020

    QSPainRelief’s first patient event took place as part of Pain Alliance Europe’s (PAE) annual General Assembly (GA) Meeting this year: Our project’s scientific coordinator, Prof. Dr. Liesbeth de Lange, presented the scope of the project in a 20-min lecture on Wednesday, 24 June 2020. The talk was well-received by the audience of 23 laymen and representatives of European pain patient organisations from 19 different countries. Click below to watch the lecture video on YouTube!

  • QSPainRelief first patient event: At 2:30 pm this Wednesday, Prof. Liesbeth de Lange speaks at PAE’s Annual Meeting!

    22 June 2020

    QSPainRelief’s first patient event will take place as part of Pain Alliance Europe’s (PAE) annual meeting this Wednesday. Our project’s scientific coordinator, Prof. Dr. Liesbeth de Lange, will present the scope of the project in a 30-min presentation at 2:30 pm on Wednesday, 24 June 2020! If you are a PAE member joining the event, we look forward to meeting you during Liesbeth’s talk and hear your feedback and questions regarding our research. We also hope you will help us make QSPainRelief known in your local and online patient community!

  • Dissemination & Communication Plan ready

    25 March 2020

    ULEI, ISB, and concentris have developed the “Dissemination & Communication Plan” (D9.1), a confidential 40+ page important document for the entire consortium that identifies key stakeholders, and outlines a detailed strategy as well as tasks, responsibilities and target release dates for internal communication, dissemination towards target groups, training activities, exploitation, and protection of intellectual property rights (IPR) for the duration of the project. D9.1 is available for download from the intranet for all project partners and SEAB members.

    Download here
  • Honorary Doctorate for Liesbeth de Lange – congrats!

    05 February 2020

    Professor Elizabeth de Lange was honoured on 31 January 2020 by the University of Uppsala, which appointed her Honorary Doctor at the end of 2019. During the ceremony, De Lange received all three symbols of honour for an Honorary Doctorate: a hat, a diploma, and a ring. ‘An incredibly wonderful experience!’ and ‘Wherever possible, I work with Uppsala and will continue to do so. Uppsala has become a second home to me.’ Liesbeth says about the ceremony and her Swedish colleagues.

  • Successful Kick-off Meeting in Leiden!

    24 January 2020

    QSPainRelief successfully kicked off in Leiden, The Netherlands, from 22-24 January 2020. Consortium members outlined the work ahead over the next 12 months, made first decisions, and incorporated valuable feedback from the scientific and ethics advisory board.

  • The QSPainRelief project starts today!

    01 January 2020

    Today, the 5-year long, pan-European research project begins. All of us are excited to roll up our sleeves and get to work! A total of 10 QSPainRelief work packages (WPs) will cover the entire value chain of research and development, from discovery to market preparation.